Ocrelizumab
Promising Phase III Results: OCREVUS (Ocrelizumab) Subcutaneous Injection Offers Convenient and Efficient Treatment for Multiple Sclerosis
SG Tylor
Source – Roche On 13 July Roche announced positive results from the Phase III OCARINA II trial, which investigated the ...
